ALBIREO PHARMA, INC. Quarterly Return On Equity in % from Q2 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Albireo Pharma, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2012 to Q3 2022.
  • Albireo Pharma, Inc. Return On Equity for the quarter ending September 30, 2022 was -97.6 %, a 218% decline year-over-year.
  • Albireo Pharma, Inc. annual Return On Equity for 2021 was -22 %, a 69.6% increase from 2020.
  • Albireo Pharma, Inc. annual Return On Equity for 2020 was -72.3 %, a 22.2% decline from 2019.
  • Albireo Pharma, Inc. annual Return On Equity for 2019 was -59.2 %, a 82.5% decline from 2018.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -97.6 -66.9 -218% Jul 1, 2022 Sep 30, 2022
Q2 2022 -23.4 +59.5 +71.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -21.2 +55 +72.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -22 +50.3 +69.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -30.7 +40.6 +56.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -82.9 -0.88 -1.07% Apr 1, 2021 Jun 30, 2021
Q1 2021 -76.1 -3.29 -4.52% Jan 1, 2021 Mar 31, 2021
Q4 2020 -72.3 -13.1 -22.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -71.2 -8.53 -13.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -82.1 -30.3 -58.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -72.8 -25.8 -54.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -59.2 -26.8 -82.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -62.7 -35.1 -127% Jul 1, 2019 Sep 30, 2019
Q2 2019 -51.7 -26.7 -107% Apr 1, 2019 Jun 30, 2019
Q1 2019 -47 -26.1 -125% Jan 1, 2019 Mar 31, 2019
Q4 2018 -32.4 +8.13 +20.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -27.6 +29.9 +52% Jul 1, 2018 Sep 30, 2018
Q2 2018 -25 +41.1 +62.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -20.9 +43.6 +67.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -40.6 +12.9 +24.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -57.6 -14 -32.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -66.2 Apr 1, 2017 Jun 30, 2017
Q1 2017 -64.6 Jan 1, 2017 Mar 31, 2017
Q4 2016 -53.5 Oct 1, 2016 Dec 31, 2016
Q3 2016 -43.6 Jul 1, 2016 Sep 30, 2016
Q2 2015 -89.8 -43.3 -93.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -99.9 -36.1 -56.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -98.8 -37.4 -61% Oct 1, 2014 Dec 31, 2014
Q3 2014 -57.1 +8.11 +12.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -46.5 +36.8 +44.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -63.9 +4.4 +6.45% Jan 1, 2014 Mar 31, 2014
Q4 2013 -61.3 +0.29 +0.47% Oct 1, 2013 Dec 31, 2013
Q3 2013 -65.2 -2.14 -3.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -83.3 -52.1 -167% Apr 1, 2013 Jun 30, 2013
Q1 2013 -68.3 Jan 1, 2013 Mar 31, 2013
Q4 2012 -61.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -63 Jul 1, 2012 Sep 30, 2012
Q2 2012 -31.2 Apr 1, 2012 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.